**Affordable Anti-Obesity Pill Development in India**
In a significant effort to combat the rising obesity crisis in India, two prominent pharmaceutical companies, Sun Pharma Laboratories Ltd and Lupin Ltd, are collaborating to develop an affordable anti-obesity pill. This initiative comes as both companies have submitted their proposals to the Drugs Controller General of India (DCGI) for regulatory approval to advance their projects.
Currently, popular anti-obesity medications such as Eli Lilly’s Mounjaro, which is available in an injectable format, and Novo Nordisk’s Wegovy, offered as both a pill and an injection, present challenges in terms of accessibility and patient comfort. While there is no comparative data on the effectiveness of oral versus injectable semaglutide, experts suggest that the injectable variant may be more effective for weight loss due to its higher dosage and better absorption.
The DCGI’s Subject Expert Committee has granted Sun Pharma permission to initiate a large-scale clinical trial for its semaglutide tablets. Meanwhile, Lupin has received approval to conduct a bioequivalence study, which aims to demonstrate that its generic version functions similarly to the original branded drug. This development is crucial as obesity is increasingly recognized as a public health issue in India, with projections indicating that by 2050, the country could have up to 450 million overweight and obese adults.
Dr. Sharan Shivaraj Patil, Chairman of the SPARSH group of hospitals, emphasized the urgency of addressing obesity, describing it as a silent yet serious threat to public health. He noted that obesity exacerbates various medical conditions, including arthritis and diabetes, and called for a national recognition of obesity as a critical challenge. Dr. Patil advocates for a combined effort at both individual and policy levels to effectively tackle obesity and promote a healthier India.
In addition to Sun Pharma and Lupin, other Indian companies are also exploring the development of weight-loss drugs, particularly in injectable forms, as the race to provide effective solutions for obesity continues.
**FAQ**
**What are the main companies involved in developing the anti-obesity pill in India?**
Sun Pharma Laboratories Ltd and Lupin Ltd are the primary companies working on creating an affordable anti-obesity pill in India.